Cadence Bank Sells 1,042 Shares of Eli Lilly and Company $LLY

Cadence Bank reduced its stake in Eli Lilly and Company by 9.1% in the fourth quarter, selling 1,042 shares and retaining 10,349 shares valued at approximately $11.12 million. Despite this, Eli Lilly delivered strong Q1 results, beating estimates and raising its FY2026 guidance, leading to analyst upgrades and a “Moderate Buy” consensus. While Cadence Bank decreased its holdings, major institutional investors like Vanguard and Capital Research Global Investors increased their positions, with institutional ownership standing at 82.53%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin